How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

253 results for

Wellens Syndrome

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

61. Wolff-Parkinson-White Syndrome (Diagnosis)

P, et al. Electrophysiological evaluation of asymptomatic ventricular pre-excitation in children and adolescents. Int J Cardiol . 2005 Feb 15. 98(2):207-14. . Durrer D, Schuilenburg RM, Wellens HJ. Pre-excitation revisited. Am J Cardiol . 1970 Jun. 25(6):690-7. . Pappone C, Vicedomini G, Manguso F, et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation . 2012 (...) Wolff-Parkinson-White Syndrome (Diagnosis) Wolff-Parkinson-White Syndrome: Practice Essentials, Background, Pathophysiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTU5MjIyLW92ZXJ2aWV3 processing > Wolff

2014 eMedicine Emergency Medicine

62. Wolff-Parkinson-White Syndrome (Overview)

P, et al. Electrophysiological evaluation of asymptomatic ventricular pre-excitation in children and adolescents. Int J Cardiol . 2005 Feb 15. 98(2):207-14. . Durrer D, Schuilenburg RM, Wellens HJ. Pre-excitation revisited. Am J Cardiol . 1970 Jun. 25(6):690-7. . Pappone C, Vicedomini G, Manguso F, et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation . 2012 (...) Wolff-Parkinson-White Syndrome (Overview) Wolff-Parkinson-White Syndrome: Practice Essentials, Background, Pathophysiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache=aHR0cHM6Ly9lbWVkaWNpbmUubWVkc2NhcGUuY29tL2FydGljbGUvMTU5MjIyLW92ZXJ2aWV3 processing > Wolff

2014 eMedicine Emergency Medicine

63. Supraventricular Tachycardia, Wolff-Parkinson-White Syndrome (Overview)

P, et al. Electrophysiological evaluation of asymptomatic ventricular pre-excitation in children and adolescents. Int J Cardiol . 2005 Feb 15. 98(2):207-14. . Durrer D, Schuilenburg RM, Wellens HJ. Pre-excitation revisited. Am J Cardiol . 1970 Jun. 25(6):690-7. . Pappone C, Vicedomini G, Manguso F, et al. Risk of malignant arrhythmias in initially symptomatic patients with Wolff-Parkinson-White syndrome: results of a prospective long-term electrophysiological follow-up study. Circulation . 2012 (...) Supraventricular Tachycardia, Wolff-Parkinson-White Syndrome (Overview) Wolff-Parkinson-White Syndrome: Practice Essentials, Background, Pathophysiology Edition: No Results No Results Please confirm that you would like to log out of Medscape. If you log out, you will be required to enter your username and password the next time you visit. https://profreg.medscape.com/px/getpracticeprofile.do?method=getProfessionalProfile&urlCache

2014 eMedicine Pediatrics

64. Wellens’ syndrome in a 24-year-old woman (PubMed)

Wellens’ syndrome in a 24-year-old woman Wellens' syndrome refers to specific ECG abnormalities in the precordial T-wave segment, which are associated with critical stenosis of the proximal left anterior descending (LAD) coronary artery culminating in an acute anterior wall myocardial infarction (MI) if the patient is not urgently revascularised. We describe the youngest reported presentation of Wellens' syndrome in a 24-year-old woman with unstable chest pain, characteristic ECG changes (...) and slight troponin biomarker elevation. This was initially unrecognised by the emergency department as unstable coronary syndrome and she subsequently progressed to an anterior non-ST elevation MI (NSTEMI). Her coronary angiogram showed critical narrowing of the proximal LAD which was successfully treated with a drug-eluting stent.

Full Text available with Trip Pro

2013 BMJ case reports

65. Wellen's syndrome: An ominous EKG pattern (PubMed)

Wellen's syndrome: An ominous EKG pattern Wellen's syndrome is a characteristic T-wave on an electrocardiogram during a pain-free period in a patient with intermittent chest pain. This finding suggests a high-degree stenosis of the proximal left anterior descending (LAD) coronary artery that will soon result in an acute anterior wall myocardial infarction (MI) if the patient is not urgently catheterized and the occlusion opened. This case report discusses a young male patient with no known (...) cardiac disease with an EKG that demonstrates the classic Wellen's T-waves. He was urgently taken to cardiac catheterization and his 95% proximal LAD stenosis was reduced via drug-eluding stent. Through knowledge of Wellen's T-waves, more anterior wall MIs can be prevented.

Full Text available with Trip Pro

2009 Journal of Emergencies, Trauma and Shock

66. Wellens' syndrome: significance of ECG pattern recognition in the emergency department. (PubMed)

Wellens' syndrome: significance of ECG pattern recognition in the emergency department. Wellens' syndrome describes a characteristic pattern of ECG T-wave changes in association with critical narrowing of the left anterior descending coronary artery. Failure to diagnose this condition, with subsequent inappropriate management, may have fatal consequences. A case of Wellens' syndrome is reported in a young man presenting with "atypical chest pain" and the significance of its prompt recognition

2009 Emergency Medicine Journal

67. Guidelines on Supraventricular Tachycardia (for the management of patients with)

tachycardia 19 11.1.1.1 Physiological sinus tachycardia 19 11.1.1.2 Inappropriate sinus tachycardia 19 11.1.1.2.1 Diagnosis 19 11.1.1.2.2 Therapy 19 11.1.1.3 Sinus node re-entrant tachycardia 20 11.1.1.3.1 Diagnosis 20 11.1.1.3.2 Therapy 20 11.1.1.4 Postural orthostatic tachycardia syndrome 20 11.1.1.4.1 Diagnosis 20 11.1.1.4.2 Therapy 21 11.1.2 Focal atrial tachycardia 21 11.1.2.1 Diagnosis 21 11.1.2.2 Acute therapy 21 11.1.2.3 Catheter ablation 21 11.1.2.4 Chronic therapy 23 11.1.3 Multifocal atrial (...) atrioventricular nodal re-entrant tachycardia 30 11.2.1.2 Therapy 30 11.2.1.2.1 Acute therapy 31 11.2.1.2.2 Catheter ablation 31 11.2.1.2.3 Chronic therapy 31 11.2.2 Non-re-entrant junctional tachycardias 32 11.3 Atrioventricular arrhythmias 32 11.3.1 Accessory pathways 32 11.3.2 Wolff Parkinson White syndrome 33 11.3.3 Orthodromic atrioventricular re-entrant tachycardia 33 11.3.4 Antidromic atrioventricular re-entrant tachycardia 34 11.3.5 Accessory pathway as a bystander 34 11.3.6 Pre-excited atrial

Full Text available with Trip Pro

2019 European Society of Cardiology

68. Guidelines on Diagnosis and Management of Syncope

1914 5.2.5.2 Alpha-agonists 1914 5.2.5.3 Beta-blockers 1915 5.2.5.4 Other drugs 1915 5.2.5.5 Emerging new therapies in specific subgroups 1915 5.2.6 Cardiac pacing 1915 5.2.6.1 Evidence from trials in suspected or certain reflex syncope and electrocardiogram- documented asystole 1915 5.2.6.2 Evidence from trials in patients with carotid sinus syndrome 1915 5.2.6.3 Evidence from trials in patients with tilt-induced vasovagal syncope 1916 5.2.6.4 Evidence from trials in patients with adenosine (...) -sensitive syncope 1917 5.2.6.5 Choice of pacing mode 1917 5.2.6.6 Selection of patients for pacing and proposed algorithm 1917 5.3 Treatment of orthostatic hypotension and orthostatic intolerance syndromes 1919 5.3.1 Education and lifestyle measures 1919 5.3.2 Adequate hydration and salt intake 1919 5.3.3 Discontinuation/reduction of vasoactive drugs 1919 5.3.4 Counter-pressure manoeuvres 1920 5.3.5 Abdominal binders and/or support stockings 1920 5.3.6 Head-up tilt sleeping 1920 5.3.7 Midodrine 1920

Full Text available with Trip Pro

2018 European Society of Cardiology

69. Heart Disease and Stroke Statistics

. Physical Inactivity e99 5. Nutrition e119 6. Overweight and Obesity e138 Health Factors and Other Risk Factors 7. High Blood Cholesterol and Other Lipids e161 8. High Blood Pressure e174 9. Diabetes Mellitus e193 10. Metabolic Syndrome e212 11. Kidney Disease e233 12. Sleep e249 Cardiovascular Conditions/Diseases 13. Total Cardiovascular Diseases e257 14. Stroke (Cerebrovascular Disease) e281 15. Congenital Cardiovascular Defects and Kawasaki Disease e327 16. Disorders of Heart Rhythm e346 17. Sudden (...) Cardiac Arrest, Ventricular Arrhythmias, and Inherited Channelopathies e377 18. Subclinical Atherosclerosis e401 19. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris e415 20. Cardiomyopathy and Heart Failure e438 21. Valvular Diseases e455 22. Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism), Chronic Venous Insufficiency, Pulmonary Hypertension e472 23. Peripheral Artery Disease and Aortic Diseases e481 Outcomes 24. Quality of Care e497 25. Medical Procedures

Full Text available with Trip Pro

2019 American Heart Association

70. Fourth Universal Definition of Myocardial Infarction

252 15 Re-infarction 252 16 Myocardial injury and infarction associated with cardiac procedures other than revascularization 252 17 Myocardial injury and infarction associated with non-cardiac procedures 252 18 Myocardial injury or infarction associated with heart failure 253 19 Takotsubo syndrome 253 20 Myocardial infarction with non-obstructive coronary arteries 254 21 Myocardial injury and/or infarction associated with kidney disease 254 22 Myocardial injury and/or infarction in critically ill (...) in clinical trials 262 38 Silent/unrecognized myocardial infarction in epidemiological studies and quality programmes 263 39 Individual and public implications of the myocardial infarction definition 263 40 Global perspectives of the definition of myocardial infarction 263 41 Using the Universal Definition of Myocardial Infarction in the healthcare system 263 42 Appendix 264 43 Acknowledgements 264 44 References 264 Abbreviations and acronyms ACC American College of Cardiology ACS Acute coronary syndrome

Full Text available with Trip Pro

2018 European Society of Cardiology

71. 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope

. Inheritable Arrhythmic Conditions: Recommendations e81 4.3.1. Brugada Syndrome: Recommendations e81 4.3.2. Short-QT Syndrome: Recommendation e82 4.3.3. Long-QT Syndrome: Recommendations e82 4.3.4. Catecholaminergic Polymorphic Ventricular Tachycardia: Recommendations e83 4.3.5. Early Repolarization Pattern: Recommendations e84 5. Reflex Conditions: Recommendations e84 5.1. Vasovagal Syncope: Recommendations e84 5.2. Pacemakers in Vasovagal Syncope: Recommendation e85 5.3. Carotid Sinus Syndrome (...) to October 2015. Key search words included but were not limited to the following: athletes, autonomic neuropathy, bradycardia, carotid sinus hypersensitivity, carotid sinus syndrome, children, death, dehydration, diagnosis, driving, electrocardiogram, electrophysiological study, epidemiology, falls, implantable loop recorder, mortality, older populations, orthostatic hypotension, pediatrics, psychogenic pseudosyncope, recurrent syncope, risk stratification, supraventricular tachycardia, syncope unit

2017 American Heart Association

72. Heart Disease and Stroke Statistics 2017 Update: A Report From the American Heart Association

. . . . . . . . . . . . . . . . . e295 11. Metabolic Syndrome . . . . . . . . . . . . . . . e313 12. Chronic Kidney Disease . . . . . . . . . . . . . e336 Cardiovascular Conditions/Diseases 13. Total Cardiovascular Diseases . . . . . . . . . . e349 14. Stroke (Cerebrovascular Disease). . . . . . . . . e374 15. Global CVD and Stroke . . . . . . . . . . . . . . e414 16. Congenital Cardiovascular Defects and Kawasaki Disease . . . . . . . . . . . . . . . . e423 17. Disorders of Heart Rhythm . . . . . . . . . . . . e440 18. Sudden (...) Cardiac Arrest . . . . . . . . . . . . . . e468 19. Subclinical Atherosclerosis . . . . . . . . . . . . e487 20. Coronary Heart Disease, Acute Coronary Syndrome, and Angina Pectoris. . . . . . . . . . e505 21. Cardiomyopathy and Heart Failure . . . . . . . . e523 22. Valvular Diseases . . . . . . . . . . . . . . . . e539 23. Venous Thromboembolism (Deep Vein Thrombosis and Pulmonary Embolism), Chronic Venous Insufficiency, Pulmonary Hypertension. . . e548 24. Peripheral Artery Disease and Aortic

Full Text available with Trip Pro

2017 American Heart Association

73. 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non?ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures

and statements that would potentially impact the construct of the measures. The practice guidelines and statements that most directly contributed to the development of these measures are summarized in . Table 2. Associated Guidelines and Other Clinical Guidance Documents Clinical Practice Guidelines 1. 2014 AHA/ACC Guideline for the Management of Patients With Non–ST-Elevation Acute Coronary Syndromes 2. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction 3. AHA/ACCF Secondary (...) -elevation myocardial infarction; NSTE-ACS, non–ST-segment elevation acute coronary syndromes; PM, performance measure; and STEMI, ST-elevation myocardial infarction. 3.1.3. New Measures The new measure set includes 4 performance measures and 7 quality measures. includes a list of the new measures and their rationale. Table 6. New STEMI/NSTEMI Measures No. Care Setting Measure Title Rationale for Creating New Measure Rationale for Designating as a Quality Measure as Opposed to a Performance Measure

2017 American Heart Association

74. Atrial Fibrillation

9.7.1 Antithrombotic therapy after acute coronary syndromes and percutaneous coronary intervention in patients requiring oral anticoagulation 51 10 Rate control therapy in atrial fibrillation 53 10.1 Acute rate control 53 10.2 Long-term pharmacological rate control 54 10.2.1 Beta-blockers 54 10.2.2 Non-dihydropyridine calcium channel blockers 54 10.2.3 Digitalis 54 10.2.4 Amiodarone 55 10.3 Heart rate targets in atrial fibrillation 55 10.4 Atrioventricular node ablation and pacing 56 11 Rhythm (...) syndrome 75 13.2.2 Hypertrophic cardiomyopathy 75 13.2.3 Channelopathies and arrhythmogenic right ventricular cardiomyopathy 76 13.3 Sports and atrial fibrillation 77 13.4 Pregnancy 77 13.4.1 Rate control 77 13.4.2 Rhythm control 78 13.4.3 Anticoagulation 78 13.5 Post-operative atrial fibrillation 78 13.5.1 Prevention of post-operative atrial fibrillation 78 13.5.2 Anticoagulation 79 13.5.3 Rhythm control therapy in post-operative atrial fibrillation 79 13.6 Atrial arrhythmias in grown-up patients

Full Text available with Trip Pro

2016 European Society of Cardiology

75. The Interventionalist Refuses Angiography, and even to speak to the Emergency Physician

inversion after resolution of pain (ECG 2). Looks like Wellens' in V1 only! This ECG is typical of the rare isolated right ventricular STEMI. There is also some very minimal inferior STE, with reciprocal STD in aVL, which is gone after reperfusion (ECG 2). The very narrow-based, peaked T-waves would be an unusual manifestation of MI. There is quite a bit of diffuse T-wave peaking. Hyperkalemia can result in ST elevation in V1 and V2, so one might wonder about hyperkalemia, although such ECGs really look (...) in spite of medical treatment who is having acute coronary syndrome should go emergently to the Cath Lab. This is by the recommendations of their own societies . ACC/AHA Guidelines for the management of Non ST Segment Elevation Myocardial Infarction. And this is regardless of the ECG findings ." "Moreover, in this case you have ST Elevation in V1. This is an RV infarct." I continued: "The European society of Cardiology recommends emergent and angiography for patients even with normal biomarkers if you

2019 Dr Smith's ECG Blog

76. 15 yo AAM with ST Elevation and T-wave Inversion. Hypertrophic Cardiomyopathy or Normal ("Variant")?

(in contrast to Wellens' syndrome, in which they are V2-V4) 4. The T-wave inversion does not evolve and is generally stable over time (in contrast to Wellens', ). 5. The leads with T-wave inversion (left precordial) usually have some ST elevation 6. Right precordial leads often have ST elevation typical of classic early repolarization 7. The T-wave inversion in leads V4-V6 is preceded by minimal S-waves 8. The T-wave inversion in leads V4-V6 is preceded by high R-wave amplitude 9. The QRS is not at all (...) disorder. In addition to HCM — other entities that might be suggested by an abnormal ECG include congenital long QT syndrome, Brugada syndrome, and RV dysplasia ( all very important, but very rare syndromes ) — leaving greatest potential benefit to accrue from detecting HCM. That said, the approach to screening remains highly controversial with lack of consensus ( and beyond the scope of my discussion here ). Who should be screened? It is probably “wishful thinking” that random ECG screening

2019 Dr Smith's ECG Blog

77. What will you do for this patient transferred to you who is now asymptomatic?

of a practitioner with advanced ECG interpretation training. The same reasoning applies to patients with unequivocal ECG evidence of reperfusion from Occlusion MI (Wellens syndrome, e.g. reperfusion of anterior Occlusion MI without recorded ECG during occlusion). Both groups of patients are at very high risk of reocclusion, and reocclusion may be clinically silent or too late to prevent myocardial loss or death. =================================================================== Timing of Reperfusion Therapy (...) maximal medical therapy in an ICU setting with continuous 12-lead ST segment monitoring under the close attention of a practitioner with advanced ECG interpretation training. The same reasoning applies to patients with unequivocal ECG evidence of reperfusion from Occlusion MI (Wellens syndrome, e.g. reperfusion of anterior Occlusion MI without recorded ECG during occlusion). Both groups of patients are at very high risk of reocclusion, and reocclusion may be clinically silent or too late to prevent

2019 Dr Smith's ECG Blog

78. A woman in her 70s with chest pain

of the image) of Wellens/reperfusion from Smith et al, Acute Coronary Syndromes, EM Clinics of North America 2006. The patient had an uncomplicated course after PCI and was discharged two days after the procedure. Teaching Points: In the presence of a normal QRS (in particular, in the absence of QRS abnormalities such as LBBB or LVH, t he combination of STE in V1 and STD in V5 and V6 is very specific for septal transmural ischemia. The value of repeat ECGs cannot be overstated. While the initial ECG (...) associated with ST depression in other precordial leads (in this case, V5 and V6) Anonymous Wellens syndrome? Indeed, but in this case, the occlusion EKG was recorded (the EKG during pain, with upright Ts). Subscribe to: Recommended Resources , . Dr. Stephen W. Smith is a faculty physician in the at Hennepin County Medical Center (HCMC) in Minneapolis, MN, and Professor of Emergency Medicine at the . This work is licensed under a . Disclaimer Cases come from all over the world. Patient identifiers have

2019 Dr Smith's ECG Blog

79. Drugs That May Cause or Exacerbate Heart Failure

of Care and Outcomes Research Originally published 11 Jul 2016 Circulation. 2016;134:e32–e69 You are viewing the most recent version of this article. Previous versions: Abstract Heart failure is a common, costly, and debilitating syndrome that is associated with a highly complex drug regimen, a large number of comorbidities, and a large and often disparate number of healthcare providers. All of these factors conspire to increase the risk of heart failure exacerbation by direct myocardial toxicity (...) and other comorbidities, as well as the increasing comorbidity burden in an aging population that may warrant an increasing number of specialist and provider visits. , The HF syndrome is accompanied by a broad spectrum of both cardiovascular and noncardiovascular comorbidities. Five or more cardiovascular and noncardiovascular chronic conditions are present in 40% of Medicare patients with HF. This estimate is much higher compared with the general Medicare population, in which only 7.6% have ≥3 chronic

Full Text available with Trip Pro

2016 American Heart Association

80. Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association

in caution against the use of ß-blockers in cocaine-related cardiac presen- tations. Therefore, the routine use of propranolol and subsequently all ß 1 -specific blockers was not recom- mended in the acute setting of cocaine-related acute coronary syndrome. 100 On the other hand, the safety and efficacy of ß-blockers in patients with chronic HF or car- diomyopathy related to cocaine are unknown. ß-Blockers with a-blocking properties such as carvedilol (an a 1 -, ß 1 -, and ß 2 -receptor antagonist) might (...) - ticularly in areas of the world such as those with very high incidence. 163 Genetic predisposition and familial syndromes have been recognized in women with PPCM, with a similar rate to that seen in other forms of primary nonischemic DCM. 168,169 A genome-wide association analysis discovered and replicated a novel genomic lo- cus linked to an increased risk of PPCM at chromosome 12p11.22, 170 providing further supporting evidence of a genetic pathogenesis for PPCM. prognosis Although prognosis appears

Full Text available with Trip Pro

2016 American Heart Association

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>